| Pan‑cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS‑CoV‑2 infection leading to COVID-19 P Katopodis, V Anikin, HS Randeva, DA Spandidos, K Chatha, I Kyrou, ... International Journal of Oncology 57 (2), 533-539, 2020 | 48 | 2020 |
| Kinase inhibitors and ovarian cancer P Katopodis, D Chudasama, G Wander, L Sales, J Kumar, M Pandhal, ... Cancers 11 (9), 1357, 2019 | 32 | 2019 |
| COVID‑19 and SARS‑CoV‑2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease P Katopodis, R Kerslake, J Davies, HS Randeva, K Chatha, M Hall, ... International journal of molecular medicine 47 (4), 1-7, 2021 | 28 | 2021 |
| Electrochemotherapy with bleomycin and cisplatin enhances cytotoxicity in primary and metastatic uveal melanoma cell lines in vitro M Fiorentzis, H Kalirai, P Katopodis, B Seitz, A Viestenz, SE Coupland Neoplasma 65 (2), 210-215, 2018 | 26 | 2018 |
| Host cell entry mediators implicated in the cellular tropism of SARS‑CoV‑2, the pathophysiology of COVID‑19 and the identification of microRNAs that can modulate the expression … P Katopodis, HS Randeva, DA Spandidos, S Saravi, I Kyrou, E Karteris International journal of molecular medicine 49 (2), 1-12, 2022 | 25 | 2022 |
| Pathophysiology of drug-induced hypomagnesaemia P Katopodis, E Karteris, KP Katopodis Drug safety 43 (9), 867-880, 2020 | 25 | 2020 |
| Conjunctival melanoma and electrochemotherapy: preliminary results using 2D and 3D cell culture models in vitro M Fiorentzis, P Katopodis, H Kalirai, B Seitz, A Viestenz, SE Coupland Acta ophthalmologica 97 (4), e632-e640, 2019 | 25 | 2019 |
| Endometrial changes in estrogen and progesterone receptor expression during implantation in an oocyte donation program E Klonos, P Katopodis, E Karteris, E Papanikolaou, B Tarlatzis, G Pados Experimental and Therapeutic Medicine 20 (6), 1-1, 2020 | 19 | 2020 |
| p38β-MAPK11 and its role in female cancers P Katopodis, R Kerslake, A Zikopoulos, N Beri, V Anikin Journal of Ovarian Research 14 (1), 84, 2021 | 17 | 2021 |
| Liquid biopsies in lung cancer: Four emerging technologies and potential clinical applications D Chudasama, P Katopodis, N Stone, J Haskell, H Sheridan, B Gardner, ... Cancers 11 (3), 331, 2019 | 17 | 2019 |
| Acid-base abnormalities and liver dysfunction P Katopodis, EM Pappas, KP Katopodis Annals of Hepatology 27 (2), 100675, 2022 | 13 | 2022 |
| The effect of dialysis modality and membrane performance on native immunity in dialysis patients PM Efthymios, M Spiridoula, K Periklis, C Andreas, T Sotiris, E Theodoros, ... prilozi 40 (2), 25-32, 2019 | 9 | 2019 |
| In silico and in vitro analysis of lncRNA XIST reveals a panel of possible lung cancer regulators and a five-gene diagnostic signature P Katopodis, Q Dong, H Halai, CI Fratila, A Polychronis, V Anikin, C Sisu, ... Cancers 12 (12), 3499, 2020 | 7 | 2020 |
| Circulating tumour cells and circulating cell-free DNA in patients with lung cancer: a comparison between thoracotomy and video-assisted thoracoscopic surgery P Katopodis, V Anikin, U Kishore, T Carter, M Hall, N Asadi, A Polychronis, ... BMJ Open Respiratory Research 8 (1), e000917, 2021 | 6 | 2021 |
| Image analysis of 3d conjunctival melanoma cell cultures following electrochemotherapy M Fiorentzis, P Katopodis, H Kalirai, B Seitz, A Viestenz, SE Coupland Biomedicines 8 (6), 158, 2020 | 6 | 2020 |
| Protein expression of transmembrane protease serine 4 in the gastrointestinal tract and in healthy, cancer, and SARS‑CoV‑2 infected lungs R Kerslake, HS Randeva, D Jonigk, C Werlein, JL Robertus, P Katopodis, ... Molecular medicine reports 25 (4), 1-6, 2022 | 5 | 2022 |
| Molecular characteristics of uveal melanoma and intraocular tumors P Katopodis, MS Khalifa, V Anikin Oncology letters 21 (1), 1-1, 2021 | 5 | 2021 |
| Adipophilin expression in primary and metastatic uveal melanoma: a pilot study M Fiorentzis, H Kalirai, P Katopodis, SE Coupland Graefe's Archive for Clinical and Experimental Ophthalmology 255, 1049-1051, 2017 | 5 | 2017 |
| Canonical NF-κB promotes lung epithelial cell tumour growth by downregulating the metastasis suppressor CD82 and enhancing epithelial-to-Mesenchymal cell transition E Roupakia, E Chavdoula, G Karpathiou, G Vatsellas, D Chatzopoulos, ... Cancers 13 (17), 4302, 2021 | 4 | 2021 |
| Differential Expression of RAD51AP1 in Ovarian Cancer: Effects of siRNA In Vitro A Filipe, P Katopodis, D Chudasama, R Kerslake, J Jeyaneethi, V Anikin, ... Journal of Personalized Medicine 12 (2), 201, 2022 | 1 | 2022 |
